New Results
The IMPDH inhibitor merimepodib suppresses SARS-CoV-2 replication in vitro
Natalya Bukreyeva, Emily K. Mantlo, Rachel A. Sattler, Cheng Huang, Slobodan Paessler, Jerry Zeldis
doi: https://doi.org/10.1101/2020.04.07.028589
Natalya Bukreyeva
1Department of Pathology, University of Texas Medical Branch
Emily K. Mantlo
1Department of Pathology, University of Texas Medical Branch
Rachel A. Sattler
1Department of Pathology, University of Texas Medical Branch
Cheng Huang
1Department of Pathology, University of Texas Medical Branch
Slobodan Paessler
1Department of Pathology, University of Texas Medical Branch
Jerry Zeldis
2ViralClear, a subsidiary of BioSig, Inc
Article usage
Posted April 09, 2020.
The IMPDH inhibitor merimepodib suppresses SARS-CoV-2 replication in vitro
Natalya Bukreyeva, Emily K. Mantlo, Rachel A. Sattler, Cheng Huang, Slobodan Paessler, Jerry Zeldis
bioRxiv 2020.04.07.028589; doi: https://doi.org/10.1101/2020.04.07.028589
Subject Area
Subject Areas
- Biochemistry (12934)
- Bioengineering (9834)
- Bioinformatics (31552)
- Biophysics (16259)
- Cancer Biology (13342)
- Cell Biology (19022)
- Clinical Trials (138)
- Developmental Biology (10313)
- Ecology (15320)
- Epidemiology (2067)
- Evolutionary Biology (19555)
- Genetics (12978)
- Genomics (17937)
- Immunology (13055)
- Microbiology (30493)
- Molecular Biology (12716)
- Neuroscience (66584)
- Paleontology (490)
- Pathology (2061)
- Pharmacology and Toxicology (3547)
- Physiology (5532)
- Plant Biology (11403)
- Synthetic Biology (3169)
- Systems Biology (7834)
- Zoology (1769)